Items without sitelinks

Showing below up to 50 results in range #10,251 to #10,300.

10251. Unintentional exposure to or harmful effects of antineoplastic natural products (Q102559)
10252. Unintentional exposure to or harmful effects of other antineoplastic drugs (Q102558)
10253. Unintentional exposure to or harmful effects of antiallergic or antiemetic drugs (Q102557)
10254. Unintentional exposure to or harmful effects of antineoplastic antimetabolites (Q102556)
10255. Unintentional exposure to or harmful effects of other H1-receptor antagonists (Q102555)
10256. Unintentional exposure to or harmful effects of macrolides (Q102554)
10257. Inclusion body myopathy with Paget disease of bone and frontotemporal dementia (Q102553)
10258. Unintentional exposure to or harmful effects of diphenhydramine (Q102552)
10259. Desmin-related myopathy with Mallory body-like inclusions (Q102551)
10260. Hereditary inclusion body myopathy - joint contractures - ophthalmoplegia (Q102550)
10261. X-linked myopathy with excess autophagy (Q102549)
10262. Unintentional exposure to or harmful effects of aminoglycosides (Q102548)
10263. Unintentional exposure to or harmful effects of rifampicin (Q102547)
10264. Unintentional exposure to or harmful effects of antifungal antibiotics, systemically used (Q102546)
10265. Unintentional exposure to or harmful effects of tetracyclines (Q102545)
10266. Vestibular dysplasia (Q102544)
10267. Unintentional exposure to or harmful effects of chloramphenicol group (Q102543)
10268. Unintentional exposure to or harmful effects of penicillins (Q102542)
10269. Unintentional exposure to or harmful effects of cephalosporins or other beta-lactam antibiotics (Q102541)
10270. Secondary combined hyperlipidaemia (Q102540)
10271. Familial combined hyperlipidaemia (Q102539)
10272. Chronic childhood granulomatous disease (Q102538)
10273. Splinter in other or unspecified parts of lower leg (Q102537)
10274. Secondary hyperlipoproteinaemia type 3 (Q102536)
10275. Hyperlipidaemia type 3 - familial dyslipoproteinaemia (Q102535)
10276. Atresia of cervix in pregnancy or childbirth, causing obstructed labour (Q102534)
10277. Cervix scar in pregnancy or childbirth, causing obstructed labour (Q102533)
10278. Hyperlipidaemia type 3 - Apolipoprotein E deficiency (Q102532)
10279. Astroglioma of unspecified site (Q102531)
10280. Low grade ependymoma (Q102530)
10281. Hyperlipidaemia type 3 - familial dysbetalipoproteinaemia (Q102529)
10282. Prolapse of anterior lip of cervix obstructing labour (Q102528)
10283. Hyperlipidaemia type 3 - familial defective apolipoprotein B (Q102527)
10284. Cervix canal stricture, in pregnancy or childbirth, causing obstructed labour (Q102526)
10285. Unintentional suffocation and strangulation due to bed linen (Q102525)
10286. Cervix canal stenosis in pregnancy or childbirth, causing obstructed labour (Q102524)
10287. Strabismic diplopia (Q102523)
10288. Suffocation and strangulation due to mother's body (Q102522)
10289. Anaplastic ependymoma of brain (Q102521)
10290. Juvenile astrocytoma of unspecified site (Q102520)
10291. Pituicytoma of brain (Q102519)
10292. Subependymal giant cell astrocytoma of brain (Q102518)
10293. Mixed glioma of unspecified site (Q102517)
10294. Fibrous astrocytoma of unspecified site (Q102516)
10295. Pleomorphic xanthoastrocytoma of brain (Q102515)
10296. Diffuse astrocytoma of brain (Q102514)
10297. Pilocytic astrocytoma of brain (Q102513)
10298. Anaplastic oligodendroglioma of brain (Q102512)
10299. Anaplastic oligoastrocytoma of brain (Q102511)
10300. Ruptured circle of Willis aneurysm (Q102510)